Morpholine → HCID 58521835, compound
Reaction equation
[Br:1][C:2]1[CH:15]=[CH:14][C:5]([C:6]([N:8]([CH2:10][CH2:11]CC)[CH3:9])=[O:7])=[C:4]([S:16]([CH:19]([CH3:21])[CH3:20])(=[O:18])=[O:17])[CH:3]=1.BrC1C=CC([C:27](O)=[O:28])=C(S(C(C)C)(=O)=O)C=1.N1CCOCC1>>[Br:1][C:2]1[CH:15]=[CH:14][C:5]([C:6]([N:8]2[CH2:9][CH2:27][O:28][CH2:11][CH2:10]2)=[O:7])=[C:4]([S:16]([CH:19]([CH3:21])[CH3:20])(=[O:18])=[O:17])[CH:3]=1Participants
4
Procedure
Following the general method as outlined in Intermediate 253, starting from 4-bromo-2-(isopropylsulfonyl)benzoic acid (Intermediate 242) and morpholine, the title compound was obtained as a pink solid.
Sources & evidence
- ORD record
- ord-0e3a70f801944a59bb5b999755e2a0bf
- Source dataset
- uspto-grants-2012_09
- Patent number
- US08273769B2
Reaction notes
Loading…